Natural history assessment of Baker Gordon Syndrome
Official title: A Prospective, Longitudinal and Observational Natural History Study for Children and Adults With Baker Gordon Syndrome - Genetic Autism Alliance
Run by University of Missouri-Columbia · NCT06399952 · Data updated 2026-11-12
This study is trying to learn more about how Baker Gordon Syndrome affects people over time by tracking their symptoms and collecting important health information to help with future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 99 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Missouri-Columbia Academic / other |
| Locations | 1 site (Columbia, Missouri) |
| Status | Recruiting |
| Started | April 30, 2024 |
| Main results expected | May 5, 2027 |
| Study ends | May 5, 2027 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT06399952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals of any age with a genetically confirmed diagnosis of Baker Gordon Syndrome.
✕Probably not a fit
Patients with unrelated neurodevelopmental conditions or co-morbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to conduct a longitudinal assessment of the clinical progression of individuals with Baker Gordon Syndrome, also known as Synaptotagmin1-Associated Neurodevelopmental Disorder. It will gather baseline measurements and develop outcome measures and diagnostic tools to enhance understanding of the disorder and prepare for future clinical trials. Participants will undergo various assessments, including brain imaging, whole genome sequencing, and the collection of sleep and seizure diaries, while also providing skin samples for stem cell development to study the impact of genetic mutations. The study will focus on identifying factors that correlate with disease development and outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic strategies for patients with Baker Gordon Syndrome.
How similar studies have gone: While this study focuses on a rare condition, similar natural history studies have shown promise in understanding other neurodevelopmental disorders.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Genetically confirmed diagnosis of Baker Gordon syndrome. * 0-99 years * Ability to send medical records and diagnostic test results. * Ability to complete tests and questionnaires. Exclusion Criteria: • The presence of another condition or co-morbidity unrelated to Baker Gordon syndrome, that affects neurodevelopment. In this study, the primary caregivers/LAR for each participant diagnosed Baker Gordon Syndrome will be also considered participants. Caregivers/LAR will have to meet the following inclusion criteria: * \>18 years. * Legal caregiver of the patient diagnosed with a Baker Gordon Syndrome. * Willingness to follow study procedures, as assessed by the research team. * Willingness to sign the consent form. * Ability to understand all the information regarding the study, as assessed by the research team. Caregivers/LAR Exclusion Criteria: • Less than 18 years old.
Where it's running
-
University of Missouri Columbia
Columbia, Missouri, United States Recruiting
Study contacts
- Principal investigator: W. David Arnold, MD — University of Missouri-Columbia
- Study coordinator: W. David R Arnold, MD
- Email: wdavidarnold@health.missouri.edu
- Phone: 573-884-2924
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tegileridine for pain after bariatric surgery
This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.
-
Perinatal Autism Genetics and Epigenetics study
We’re testing whether prenatal stress and early social experiences can cause epigenetic changes linked to autism in children, by following pregnant women and their kids using a smartphone tool.
-
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
This study tests whether low intensity focused ultrasound can help reduce seizures in adults with drug‑resistant epilepsy.
-
AI-assisted Rare-Disease Diagnosis
A multicenter randomized test to see if an AI diagnostic tool can help doctors make faster, more accurate rare-disease diagnoses for patients with unresolved symptoms.
-
Socio‑professional inclusion for young people (15–25) with childhood-onset rare genetic disabilities
This project will try to see what makes it hard for 15–25‑year‑olds with childhood-onset rare genetic conditions to access higher education, internships, or work.
-
Yoga to reduce stress and improve sleep and sexual quality of life during pregnancy
We will try a researcher-led yoga program with pregnant women in their third trimester to see if it lowers stress, improves sleep, and boosts sexual quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.